Eliora G. Gachelet,1
Ellen L. Zechner,2 and
Beth Traxler1*
Department of Microbiology, University of Washington, Seattle, Washington 98195,1 Institute of Molecular Biosciences, University of Graz, A-8010 Graz, Austria2
Received 3 April 2006/ Accepted 19 June 2006
| ABSTRACT |
|---|
|
|
|---|
100-fold. Mutant TraI proteins with insertions in a region of approximately 400 residues between the consensus relaxase and helicase sequences did not cause conjugative repression. These unrestrictive TraI variants have normal relaxase activity in vivo, and several have wild-type conjugative functions when expressed at normal levels. We postulate that TraI negatively regulates conjugation by interacting with and sequestering some component of the conjugative apparatus. Our data indicate that the domain responsible for conjugative repression resides in the central region of TraI between the protein's catalytic domains. | INTRODUCTION |
|---|
|
|
|---|
The F plasmid relaxase TraI is a well-studied model of structure and function for relaxases. The single-stranded DNA-cleaving activity of TraI is present in the first
310 residues of this 1,756-residue protein, while the helicase motifs are located towards the C terminus (residues
990 to 1450) (Fig. 1) (4, 28, 41). The C-terminal region of TraI following the helicase domain appears to play a role in conjugation and may function in protein-protein interactions (28). TraI binds nic with exquisite sequence specificity (40), and some structural determinants of this specificity have been revealed by site-directed mutagenesis and crystallographic analyses (8, 13, 14, 20).
|
TnlacZ/in system (25, 26) to generate mutants with a defined 31-codon insertion (the "i31") at different positions. i31 libraries are useful tools for studying structure-function relationships and mapping functional regions within a protein because i31 lesions are vicinal in their effects. The i31 disrupts nearby protein folding, which can be deleterious to the function of the disrupted region. In some cases, however, the insert does not affect function, and such inserts allow us to identify "permissive sites" in the protein that can tolerate insertions of a moderate size. Prior applications of i31 libraries include defining the topology of transmembrane proteins, studying protein-protein interactions, mapping functional domains, and investigating the interactions of bacterial proteins with eukaryotic cells (18, 21, 22, 38, 39, 44, 45). In one study focusing on the E. coli LacI repressor, which is, like TraI, a cytoplasmic DNA binding protein, the phenotypes resulting from i31 mutations and previously characterized missense mutations at nearby positions were explicitly compared and found to agree quite well (31). We tested the phenotypes of TraI::i31 mutants in conjugation and in vivo oriT cleavage assays. Several mutations render TraI nonfunctional in conjugation, while others mark permissive sites in the protein. An analysis of mutant with insertions between the consensus relaxase and helicase domains of the protein allowed us to identify a novel role for the intervening region, which functions as a negative regulator of F plasmid conjugation. The mechanism of negative regulation is unclear, though it may represent a titration or sequestration of some vital conjugative component by TraI.
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
A derivative of the F plasmid lacking traI was generated as follows. The traI gene in F'42 (Table 1) was replaced with a PCR-amplified tetracycline resistance cassette from Tn10 by
Red recombination (7) in strain CC1254 to generate F'42
traI::tetRA ("F'
I"). The following primers were used for tetRA PCR amplification (homology to tetRA is shown in upper case): gggatatacgttatgatgagtattgcgcaggtcagatcgTTAAGACCCACTTTCACATT (forward) and tcagtctccacccagggttttctctttctgcaggtcgcggCTAAGCACTTGTCTCCTG (reverse). Only the first 27 nucleotides and the final 40 nucleotides of traI remained intact. This particular arrangement was chosen because the traI termini provided sufficient homology to the traI::i31 alleles carried on pTrc vectors (44 base pairs on either side) to allow
Red recombination. The F'
I construct was verified by PCR and by its ability to be complemented for conjugative DNA transfer by traI in trans.
To insert mutant traI alleles into the F'42, individual alleles were cut from their pTrc-based vectors using Acc65I and HindIII and recombined into the F'
I in strain XK1502 using the
Red system present on pKD46 (7). Putative recombinants were selected on lactose minimal plates containing fusaric acid (see above) and purified on lactose minimal plates. Candidates were screened by conjugative proficiency and/or PCR, and production of TraI::i31 proteins was verified by Western blotting with an i31-specific antibody (25).
For increased expression of traM and traD, these genes were cloned into pACYC184-based vectors. traM was amplified from pRFM2T75 by PCR and cloned into the pTrc99A vector using BamHI and SalI to generate p99M+. The SalI/BamHI fragment of p99M+ was cloned into those same sites in pACYC184 to generate pACYCM+. traD was cloned from pNLK5 (21) into pTrc99A (generating p99D+) using Acc65I and HindIII and then with the same restriction enzymes into pEG100 to generate pEG103.
To create low-copy recombinant oriT substrates for activity measurements of TraI-catalyzed nic cleavage in vivo, we used the pLOW2 vector described by Hansen et al. (12). A subcloned 1.2-kb BglII/PstI fragment of the IncFII R1 oriT region was excised from pGK111M0 (36) and ligated to the polylinker of pLOW2. To avoid transcription into the oriT region from the lac promoter immediately adjacent to the polylinker, a subsequent step was necessary to reverse the orientation of the insert. The polylinker of pLOW2 is flanked by dual NotI sites. NotI digestion, followed by religation of the products, generated the desired recombinant, designated pLOW2traM0oriT, with the lac promoter 1.2 kb distant from oriT.
Mutagenesis of traI.
TnlacZ/in mutagenesis (25) of traI was carried out in strain CC191 p99I+. From approximately 100,000 screened colonies, we isolated 37 plasmids with independent in-frame traI-lacZ fusions and located the insertions by sequencing outwards from the transposon. Among this set of fusions, there were 33 different insertion locations, with insertions at the Q839 and V506 codons isolated twice and the insertion at the Q6 codon isolated three times. Transposon sequences were converted to i31 inserts as described previously (25) to generate "p99traI::i31" plasmids. The resulting traI alleles contain in-frame insertions of 31 codons with a defined sequence, with 27 of the 31 codons being identical in all mutants. Mutant alleles and proteins are referred to by the codon into which the insertion occurred (e.g., E1685 or TraIiE1685). The production of TraI::i31 proteins was assayed by Coomassie staining of gels after SDS-PAGE and by Western blot detection using an i31-specific antibody (25).
Internal deletions within traI were generated using the unique BamHI site present in the i31 sequence of the p99traI::i31 plasmids as previously described (26). To generate the deletion from codons 6 to 225, the plasmids p99traI::Q6 and p99traI::E225 were digested with BamHI and PvuI, mixed, and ligated. To generate the deletion from codons 996 to 1753, p99traI::V996 and p99traI::L1753 were cut with BamHI and EcoRI and then mixed and ligated. Mutants were assayed for their abilities to produce protein by Western blotting with an anti-i31 antibody in the same manner as that used to detect full-length i31 mutant derivatives.
Quantitative conjugation.
A total of 0.1 ml of donor and HS3169 recipient overnight cultures were added to 0.8 ml LB, and the mixture was rotated slowly at 37°C for 45 min. For the initial characterization of conjugative proficiency of the traI::i31 mutations on pTrc99A, CAW400 pOX
traI was the donor strain; for all subsequent experiments, the donor was XK1502 carrying the F'42 or F'
I plasmid. pOX
traI transconjugants were selected on rich plates containing gentamicin and streptomycin, while F'lac transconjugants were selected on lactose minimal agar supplemented with leucine, isoleucine, and streptomycin. The trc promoter was not induced when donors carried traI alleles on pTrc-based plasmids since the amount of TraI present without induction was higher than that in strains carrying the wild-type F'42 (see Results).
TraI expression analysis.
For the quantitation of radiolabeled proteins, cells were diluted 1:100 from overnight cultures into M63-glycerol and grown to an optical density at 600 nm (OD600) of
0.37 with shaking at 37°C. A total of 750 µl of these cultures was labeled with 30 µCi of 35S-Met/Cys (NEG-072 EXPRE35S35S [35S] protein labeling mix from PerkinElmer Life Sciences) for 1 min and then treated with 0.05% unlabeled methionine and immediately put on ice. TraI::i31 protein was immunoprecipitated with i31-specific antiserum (25). Precipitated proteins were separated using SDS-PAGE, and TraI was quantified using a PhosphorImager (Molecular Dynamics).
For analysis by Western blotting, cells were grown to mid-log phase in rich media without IPTG induction and then harvested. Cell extracts were separated on polyacrylamide gels, and TraI derivatives were detected by Western blotting using a polyclonal anti-i31 antibody (25) or a commercial polyclonal anti-LacZ antibody (5'
3', Inc.) as the primary antibody and an alkaline-phosphatase-conjugated secondary antibody. Bound antibodies were visualized by exposure to nitro blue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate (XP). When appropriate, blots were then scanned and bands were quantified using ImageQuant software (Molecular Dynamics).
Intracellular oriT cleavage assays.
In vivo nic cleavage catalyzed by TraI and various i31 mutants was assayed with a runoff DNA synthesis technique (47) using primer 8 as previously described (17). Briefly, E. coli AG1 strains carrying a recombinant IncF oriT traM-null cleavage substrate, pLOW2traM0oriT, and an expression construct for the traI allele were grown in the presence of ampicillin, kanamycin, and 0.1 mM IPTG. Cells were harvested in exponential growth phase, and an equivalent cell mass (OD600) was used as a template for in vitro unidirectional DNA synthesis in the presence of
32P-labeled deoxynucleoside triphosphate precursors (Amersham). The reaction mixtures also contained 2 ng of a KpnI-linearized fragment of control DNA. DNA synthesis on this standard DNA fragment generates a specific product of 72 nucleotides in length, which can be easily distinguished from the 121-nucleotide product synthesized on the oriT plasmids cleaved intracellularly at nic. The control product is used to normalize the yield of each reaction. Reaction products were applied immediately to denaturing gels and resolved with a polynucleotide size marker as described previously (17). Products were visualized by autoradiography of the dried gels.
| RESULTS |
|---|
|
|
|---|
The 33 alleles (in pTrc-derived vectors) were assayed for the ability to complement transfer of the F-derived, traI-deficient plasmid pOX
traI; the results are summarized in Fig. 1. Compared to that of the pOX
traI/p99I+ control, mutant conjugation frequencies fell into four broad categories corresponding to the groups defined in Fig. 1: extremely defective (x), partially defective (class 1), wild type (class 2), and higher than wild type (class 3). Twelve alleles complemented conjugation in a manner similar to that of the wild type, revealing permissive sites scattered across the length of the protein. Ten of the 12 extremely and partially defective alleles had insertions in the helicase domain (residues
990 to 1450). Of the remaining two class 1 alleles, the reduced function of the Q6 allele is not surprising given the proximity of its insertion to active-site residues in the relaxase domain (8), but the insertion in the Q839 allele is not in a characterized functional motif. Strikingly, all mutants with i31 lesions between residues 369 and 683 were functional in conjugation and most allowed frequencies of conjugation higher those observed with wild-type traI (Fig. 1). An important corollary to this observation was that the pOX
traI/p99I+ donor had a conjugative efficiency of 8.0 x 103 transconjugants/donor, which is relatively low (approximately 1% of the conjugative efficiency of the Tra+ F plasmid under similar conditions). Some alleles, such as the A593 and L681 alleles, complemented pOX
traI 100 times better than did wild-type traI in this assay, achieving normal F transfer rates. The surprising phenotype prompted further investigation of these class 3 alleles.
nic cleavage activity is unchanged in class 3 TraI mutants. One possible explanation for the increased conjugation frequencies observed with class 3 mutants is that the site- and strand-specific cleavage catalyzed by TraI in preparation for DNA transfer could be strongly enhanced in these insertion mutants. This hypothesis was tested by measuring the level of cleavage at nic catalyzed by TraI in vivo, which was determined by using an in vitro runoff DNA synthesis assay (17). Intracellular cleavage of a recombinant oriT substrate in hosts expressing a selection of traI::i31 alleles (six class 3 and one class 2) was compared to cleavage of the same substrate in cells carrying wild-type traI (Fig. 2). One- and twofold equivalents of cell mass (as indicated by OD600) from each strain were included in the reaction mixtures; the number of viable cells in each culture was determined at cell harvest and indicated similar levels of CFU per reaction mixture. The efficiency of the runoff DNA synthesis reaction can be normalized using the specific product produced on a known amount of linear control DNA added to each reaction mixture (Fig. 2B). While this is not a strictly quantitative assay, a twofold increase in the amount of cleaved product used for in vitro DNA synthesis results in a visible difference in output (compare the one- and twofold equivalent lanes for each allele). Cells with increased TraI cleavage activity would have more cleaved product per cell and therefore result in more runoff synthesis product per viable cell input to the reaction. Despite variations in conjugative efficiency between the TraI mutants tested here, no notable difference in oriT cleavage activity was detected between the mutants (lanes 4 to 16) and wild-type TraI (lanes 2 and 3). The observation that class 3 alleles have wild-type conjugation phenotypes when present on the F'42 (see below) is further evidence that they have normal relaxase activity.
|
traI conjugation in particular, we used p99I+ and several p99traI::i31 plasmids to complement conjugative transfer of the plasmid F'
I, a derivative of the wild-type F'42 in which the traI gene was replaced with a tetracycline resistance marker (Fig. 3). In this system, we again found that p99I+ complemented plasmid transfer at an
100-fold-reduced frequency relative to that of F'42 (6.6 x 103 transconjugants/donor). All other plasmids also complemented conjugation as they had for pOX
traI: the V996 and Q1441 i31 mutants were still defective, class 2 mutants (the Q794 and E1685 mutants) still performed equivalently to the wild type, and class 3 mutants (the Q369, A593, and L681 mutants) again outperformed the wild type.
|
We next set out to test the phenotype of i31 mutants when TraI was expressed at physiological levels. While we did not induce TraI expression in our prior conjugation experiments, leaky transcription from the trc promoter on the pTrc-derived plasmids resulted in increased TraI expression relative to F'lac (see below). For complementation experiments in cis, we replaced the wild-type traI locus of F'42 with a variety of traI::i31 alleles using
Red recombination to make markerless replacements and avoid upstream or downstream lesions that might affect expression. We chose three class 3 alleles (the Q369, A593, and L681 alleles), two class 2 alleles (the Q794 and E1685 alleles), and two extremely defective alleles (the V996 and Q1441 alleles). The conjugation frequencies of the resulting F'lac plasmids were determined and compared to the F'
I/p99traI complementation data in Fig. 3. The two defective alleles tested remained defective on F'lac. The Q794 allele appeared similar to the wild type in high-copy complementations but had a severe defect when present on F'lac, while the E1685 allele was indistinguishable from the wild type in both conjugation assays. F'lac plasmids carrying any of the three class 3 alleles transferred in a manner similar to that of the wild-type F'42 (though F'traI::L681 seems somewhat defective). In summary, we observed that class 3 alleles supported robust transfer efficiencies regardless of copy number, while the wild-type traI and the functional E1685 mutation repressed conjugation when expressed from pTrc-derived plasmids. We therefore designated the class 3 alleles as "unrestrictive" to describe their inability to repress conjugative efficiency.
The inability of unrestrictive alleles to suppress conjugation at high copy suggested that the region mutated might be a negative regulatory domain. To test this conjecture, we performed conjugative dominance experiments in which wild-type traI was present on unmodified F'42 and a second allele was introduced on a pTrc derivative (Fig. 3). Conjugation frequencies ranged widely, depending upon the pTrc-expressed allele. p99I+ and p99traI::E1685 displayed negative dominance over F'42, reducing the frequency of conjugation by 2 orders of magnitude (compare F'42 or traI::i31 and F'42 + p99I+ or p99traI::i31s in Fig. 3). The V996 and Q1441 alleles, two defective alleles with lesions well outside the domain associated with unrestrictive mutations, reduced F'42 conjugation frequency in a manner similar to that of wild-type traI when present on the pTrc vector but did not show further dominance beyond that noted for p99I+. In contrast, plasmid-borne class 3 alleles (the Q369, A593, and L681 alleles) did not exhibit conjugative repression of coresident F'42. While the Q794 allele did not display negative dominance for conjugation, the Q839 allele did, suggesting that the C-terminal boundary of the "restrictive" domain lies between residues 794 and 839.
We continued our conjugative dominance experiments by determining the conjugation frequencies of two strains carrying p99I+ and F'traI::i31 plasmids (Fig. 3). The V996 allele was recessive to wild-type traI on the high-copy plasmid, while the A593 allele showed partial sensitivity to the high-copy repression. We concluded that the expression of TraI from the pTrc-derived multicopy plasmid led to a significant and dominant decrease in conjugative efficiency for coresident F'lac plasmids, which could be rescued by insertions in the region between residues 369 and 794 of TraI.
To determine whether the restrictive domain could function in the absence of the other functional domains of TraI, we used the i31 library to generate two internal deletions: an N-terminal deletion from residues 6 to 225 (deleting the majority of the relaxase domain) and a C-terminal deletion from residues 996 to 1753 (deleting the helicase and putative protein-protein interaction domains). When expressed from the pTrc vector, neither of these mutants had an effect on the conjugation frequency of a coresident F'42 plasmid in conjugative dominance experiments, but the levels of mutant proteins produced by donor cells were determined by Western blotting to be quite low relative to the levels of full-length TraI::i31 proteins (data not shown). Because the overexpression of TraI is probably a critical factor in conjugative repression (see below), we do not find it surprising that the deletion mutants failed to exert dominant effects on conjugation.
To address the question of domain sufficiency in a different way, we assayed the conjugative dominance phenotypes of a number of TraI-LacZ fusions. These fusions are generated as part of the i31 mutagenesis, so we have a TraI-LacZ translational fusion at the same position as each i31 allele in the library (see Materials and Methods). At the point of fusion, native TraI sequence ends and the sequence of LacZ follows, resulting in a C-terminally truncated TraI derivative. Various TraI-LacZ fusions were expressed from the pTrc vector in the presence of wild-type F'42; the conjugative frequencies associated with each tested donor are shown in Table 2, which also summarizes which domains are thought to be present in each mutant. Most fusion proteins had little, if any, effect on conjugative efficiency. The only fusion protein which had a considerable dominant-negative effect on conjugation was the protein with a fusion at position 1753, and this fusion caused only a fivefold decrease in conjugative efficiency (relative to
100-fold for wild-type TraI). Western blot analysis showed that all of the fusion proteins were expressed at levels comparable to those of full-length TraI::i31 proteins (data not shown). These results suggest that the restrictive domain may require the C-terminal region of the protein to function properly. We cannot, however, rule out the possibility that the tetramerization of LacZ interferes with the function of the TraI restrictive domain by sequestering it or decreasing its effective concentration within the cell.
|
7.5 times as much TraI as did those harboring F'traI::L681, and quantitative analysis of protein stability showed no degradation of TraIiL681 over 15 min (data not shown). We also used Western blotting to compare the expression levels of TraIiQ369, TraIiL681, and TraIiE1685 from F'lac and pTrc-derived plasmids (without inducing the trc promoter). Qualitatively, the ratios of TraI expression from pTrc to that from F'lac looked consistently similar; quantitation of TraI bands gave mean pTrc:F'lac expression ratios in the range of 10:1 for all three mutant proteins. We infer that cells carrying a traI allele on a pTrc-based vector, without induction of the trc promoter, express on the order of 10-fold-more TraI protein than do cells carrying the same allele on F'lac.
Increasing traD or traM copy number did not reverse repression by TraI. The conjugative repression caused by elevated levels of TraI might be the result of TraI binding to and sequestering of another protein. We considered two possible candidates for sequestration: TraM, a protein that associates with TraI and stimulates nic cleavage in the related R1 plasmid system (17, 19), and TraD, the coupling protein of the F Tra system that connects the relaxosome to the membrane-spanning DNA transfer complex (23, 38). Introduction of traM or traD on a pACYC184-based plasmid had little effect on conjugation whether traI was present at low or high copy, suggesting that neither is uniquely limiting for conjugation during traI-mediated repression (Table 3).
|
| DISCUSSION |
|---|
|
|
|---|
1 to 310 and
990 to 1450 (4, 13, 14, 16, 28, 29). Furthermore, we identified numerous "permissive sites" at which the 31-residue insertion was functionally tolerated. We also found that the expression of wild-type TraI from our multicopy plasmid led to a dominant
100-fold reduction in the frequency of conjugation. Several of the mutations did not cause a dominant decrease in conjugation frequency, though they appeared otherwise normal in conjugation and oriT cleavage assays. Using three functional alleles, we found that the high-copy pTrc vector expressed
10-fold more TraI during growth under noninducing conditions than did F'lac. We hypothesize that increased amounts of TraI protein cause the repression of conjugation and that the unrestrictive mutant proteins have a defect in the normal repressive function.
Others have previously reported that complementing a
traI strain with traI on a multicopy plasmid led to a reduction in conjugation frequency relative to the parental F-derived plasmid and speculated that the decrease in conjugation efficiency occurred because recipients were traI deficient and therefore unable to facilitate plasmid retransfer (28, 29). To test the hypothesis that a lack of plasmid retransfer could explain our data, we performed conjugation experiments in which the donors carried p99I+ in the presence of intact F'lac instead of F'
I. F transfer frequencies using these donors were reduced 100-fold relative to those of donors carrying the empty vector in place of p99I+, even though recipients were fully capable of plasmid retransfer. p99traI::Q839, p99traI::V996, and p99traI::Q1441 also displayed negative dominance in the presence of intact F'lac. p99traI::Q369, p99traI::A593, p99traI::L681, and p99traI::Q794 showed either no dominance or very modest negative dominance for conjugation, and F'traI::A593 exhibited partial resistance to conjugative repression by p99I+. Based on these observations, we rejected the retransfer hypothesis as an explanation for our results.
Taken together, our data suggest that TraI contains a negative regulatory domain that limits conjugation as TraI increases in abundance. This "restrictive" domain appears to span much of the region between the consensus relaxase and helicase sequences, encompassing at least residues 369 to 794. The presence of a negative regulatory domain in this region of TraI explains why defective mutants with lesions outside the restrictive domain (the V996 and Q1441 mutants) complemented conjugation better when expressed at single copy than at high copy, while the defective Q794 mutant complemented conjugation better at high copy than at single copy (Fig. 3). Such results highlight the complications inherent in performing complementation experiments in trans in this system.
TraIiQ839, which contains the i31 upstream of the conserved helicase domain, retains the restrictive activity, and we therefore believe that the negative regulatory domain does not overlap the consensus helicase domain. We infer that the restrictive domain does not require helicase function from the negative dominance of the V996 mutant, whose defect in conjugation is almost certainly due to a loss of helicase activity. However, we were unable to recapitulate the dominant-negative conjugation phenotype of overexpressed, wild-type TraI using internal deletions or successive C-terminal LacZ fusions. Internal deletion mutants, consistent with their lack of conjugative dominance, did not express levels of protein comparable to those of the full-length alleles. The failure of TraI-LacZ fusions to repress conjugation in trans suggests that the C-terminal region of TraI may be important for proper folding or function of the restrictive domain. Work is ongoing to assess the requirement for an intact C terminus in restrictive activity.
We observed that a 10-fold increase in TraI levels could have a large effect on the conjugative efficiency of a strain. Tenfold changes in TraI expression could conceivably occur during the lifetime of a given cell, depending on the conditions; for example, Frost and Manchak observed differential expression of TraI during different stages of growth in batch culture (10). The mechanism by which TraI's negative regulatory domain restricts conjugation remains unclear, however. This region of TraI is not similar to that of other proteins except closely related relaxases, so we cannot derive clues about its function by analogy to homologous sequences. We have ruled out the hypothesis that unrestrictive mutant proteins have an intrinsically higher single-stranded DNA cleavage activity in vivo, but it is possible that the negative regulatory domain could regulate TraI relaxase or helicase activity at some point during conjugation. However, the observation that increased TraI expression drives down conjugation frequency in trans and that this effect can be abrogated by specific mutations suggests instead that the protein may titrate out some vital component of the conjugative apparatus. Our data suggest that neither TraD nor TraM is limiting under conditions of TraI-mediated repression, but we do not rule out the sequestration of a binding partner(s) by TraI.
In conjugative dominance assays, neither of the tested helicase domain insertion mutations lowered conjugation frequencies more than wild-type TraI did. One dominant-negative helicase mutation has been described for the related relaxase TrwC, and it was postulated that the mutant protein cleaved plasmid DNA and then interfered with unwinding (24). Other helicase-defective TrwC mutants did not display negative dominance, however. Further work on the dominance of helicase mutants may shed light on the cooperativity of multiple relaxase molecules in processing plasmid DNA.
In addition to broadening our understanding of the functional domains of TraI, our mutant library allowed us to identify a number of permissive sites in the protein. These are sites at which insertions of a moderate size are tolerated, allowing experimenters to engineer in a tag or functional moiety with relative impunity. In this vein, one of our mutants has been used to construct a cuprous oxide binding derivative of TraI that enables the assembly of cuprous oxide nanoparticles under conditions in which Cu2O precipitation would normally be thermodynamically unfavorable (6). The development of other TraI derivatives with novel characteristics is ongoing.
In summary, we have generated a mutant library for assessing structure-function relationships of the F plasmid relaxase TraI. We have demonstrated the utility of this library by identifying and mapping a previously undiscovered regulatory domain with no known homologs outside of closely related relaxases. The library was generated on a cloning vector, but we recombined several different alleles onto the F plasmid in a markerless manner for complementation experiments in cis. The traI::i31 library should facilitate further characterization of the role of TraI in F plasmid conjugation, shedding light on relaxases, helicases, and the mechanisms of conjugation in general.
| ACKNOWLEDGMENTS |
|---|
We are grateful to John Hodges and Lisa Winterroth for assistance in the construction of some strains. We thank Laura Frost, Colin Manoil, and Kelly Hughes for discussions, advice, and strains that facilitated this work.
| FOOTNOTES |
|---|
Present address: Biozentrum, University of Basel, Molecular Microbiology, Klingelbergstrasse 70, CH-4056 Basel, Switzerland. ![]()
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |